149377-19-5

Basic information

• Product Name: 1-BOC-4-P-HYDROXYPHENYLPIPERIDINE
• Synonyms: 1-BOC-4-P-HYDROXYPHENYLPIPERIDINE ;4-(4-Hydroxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester;1-Boc-4-Hydroxyphenylpiperidine;tert-butyl 4-(4-hydroxyphenyl)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-(4-hydroxyphenyl)-, 1,1-dimethylethyl ester;1-Boc-4-P-Hydroxyphe
• CAS NO: 149377-19-5
• Molecular Formula: C₁₆H₂₃NO₃
• Molecular Weight: 277.35872
• Mol File: 149377-19-5.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 407.3°Cat760mmHg
• Flash Point: 200.1°C
• Appearance: /
• Density: 1.121g/cm³
• Vapor Pressure: 3.24E-07mmHg at 25°C
• Refractive Index: 1.541
• Storage Temp.: 2-8°C
• PKA: 10.15±0.30(Predicted)
• CAS DataBase Reference: 1-BOC-4-P-HYDROXYPHENYLPIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BOC-4-P-HYDROXYPHENYLPIPERIDINE(149377-19-5)
• EPA Substance Registry System: 1-BOC-4-P-HYDROXYPHENYLPIPERIDINE(149377-19-5)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 149377-19-5(Hazardous Substances Data)

Usage

General Description

1-BOC-4-P-HYDROXYPHENYLPIPERIDINE is a compound with the molecular formula C17H24N2O3. It is an organic chemical that is commonly used in the pharmaceutical industry as a building block for the synthesis of various compounds. This chemical is a piperidine derivative with a protected hydroxyl group, making it a versatile intermediate for the preparation of biologically active molecules. The BOC (tert-butoxycarbonyl) group in the compound provides protection for the amine group, allowing for selective reactions and functionalization. 1-BOC-4-P-HYDROXYPHENYLPIPERIDINE is known for its role in the synthesis of potential drug candidates and is used in medicinal chemistry research for the development of new pharmaceuticals.

InChI:InChI=1/C16H23NO3/c1-16(2,3)20-15(19)17-10-8-13(9-11-17)12-4-6-14(18)7-5-12/h4-7,13,18H,8-11H2,1-3H3

Upstream product

• 6793-92-6 p-benzyloxyphenylbromide 
• 375853-82-0 tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 106-41-2 4-bromo-phenol 
• 742067-11-4 4-(4-hydroxyphenyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 1048970-17-7 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylic acid tert-butyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1869912-48-0 4-(piperidine-4-yl)phenol hydrobromide 
• 19099-93-5 benzyl 4-oxo-1-piperidinecarboxylate 
• 541-16-2 t-butyl malonate 
• 62614-84-0 4-(4-hydroxyphenyl)-1,2,3,6-tetrahydropiperidine 
• 1166820-03-6 benzyl 4-(4-hydroxyphenyl)-5,6-dihydropyridine-1(2H)-carboxylate 
• 286961-24-8 benzyl 1,2,3,6-tetrahydro-4-(trifluoromethylsulphonyloxy)-pyridine-1-carboxylate 

Relevant articles and documents

BRAF DEGRADERS

Present invention provides compounds that cause specifically the degradation of BRAF. The present compounds are useful for the treatment of various cancers.

BET INHIBITORS FOR MODULATING DUX4 EXPRESSION IN FSHD

The present disclosure provides BET inhibitors of the formula: wherein the variables are defined herein, as well as pharmaceutical compositions thereof. The present disclosure also provides methods of treating a patient comprising administering a bromo- and extra-terminal (BET) domain inhibitor for the treatment of FSHD which modulates DUX4 expression. In some embodiments, the present methods comprise using one or more BET inhibitors as a therapeutic agent for the treatment of FSHD patients including patients who are being treated with one or more palliative treatments such as therapy and/or agents which lead to increased muscle mass.

SSAO INHIBITORS AND USES THEREOF

Described herein are compounds that are semicarbazide-sensitive amine oxidase (SSAO) inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in treating or preventing a liver disease or condition.